Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mike Aicher

Premium

Omicia has tapped Mike Aicher to serve as its CEO. He will also join the company's board of directors.

Prior to joining Omicia, Aicher served as the CEO of National Genetics Institute, a company he co-founded in 1991 that later became a wholly owned subsidiary of Laboratory Corporation of America. Most recently, he led LabCorp's western division and was also responsible for the company's esoteric business units. Before NGI, Aicher held a number of executive leadership roles at Central Diagnostics Laboratory.

Aicher obtained a Bachelor's degree in business administration from the University of Redlands and an MBA in economics from Columbus University.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.